Updated:
Genopole
Genopole is a private equity firm headquartered in Evry‑courcouronnes, France. It manages $2 million in assets. The firm concentrates its investments on the...
Overview
Genopole is a private equity firm headquartered in Evry‑courcouronnes, France. It manages $2 million in assets. The firm concentrates its investments on the biotechnology and genomics sectors. Its strategic focus is on developing a high‑level research campus dedicated to genomics, post‑genomics, and gene‑therapy initiatives. Established in 1998, Genopole’s threefold mission includes fostering advanced research infrastructure within these scientific domains. The investment approach targets companies and projects that align with its emphasis on cutting‑edge genomic and gene‑therapy research.
General information
Firm type
Private Equity
AUM
$2 million
Location
Region
Europe
Country
France
City
Evry-courcouronnes
Corporate office
Evry-courcouronnes, France
Sector focus
Frequently asked questions
What sectors does Genopole invest in?
Genopole invests in the biotechnology and genomics sectors, with a particular emphasis on gene‑therapy related research.
What is Genopole's primary mission?
Genopole’s mission is to develop a high‑level research campus in genomics and post‑genomics, focused on advancing gene‑therapy initiatives.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: